| Name | Title | Contact Details |
|---|---|---|
Sumita Ray |
General Counsel | Profile |
Retrophin is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of drugs for the treatment of debilitating and often life-threatening diseases for which there are currently limited patient options.
Neuralink is developing the capabilities of the brain through technological augmentation. A "neural lace” would be surgically connected to a human brain and allow a user to interact with a computer without the bandwidth challenges that come with current input methods, including keyboards, mice and trackpads. Neuralink will explore how brain interfaces might alleviate the symptoms of dangerous and chronic medical conditions.
Bioverativ Inc. is an American multinational biotechnology that specializes in the discovery, development, and delivery of therapies for the treatment of haemophilia.
ConjuGon Inc is a Madison, WI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Dermira is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.